265 related articles for article (PubMed ID: 31580448)
1. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.
Nikiphorou E; Norton SJ; Carpenter L; Walsh DA; Creamer P; Dixey J; Young A; Kiely PDW;
Rheumatology (Oxford); 2020 Jun; 59(6):1272-1280. PubMed ID: 31580448
[TBL] [Abstract][Full Text] [Related]
2. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
[TBL] [Abstract][Full Text] [Related]
3. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target.
Legrand J; Kirchgesner T; Sokolova T; Vande Berg B; Durez P
Joint Bone Spine; 2019 Oct; 86(5):594-599. PubMed ID: 30928534
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
Miwa Y; Saito M; Furuya H; Yanai R; Ikari Y; Hayashi T; Kasama T; Toyoshima Y; Inagaki K
Intern Med; 2017 Sep; 56(17):2271-2275. PubMed ID: 28794381
[TBL] [Abstract][Full Text] [Related]
5. The association of obesity with disease activity, functional ability and quality of life in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Study/Early Rheumatoid Arthritis Network UK prospective cohorts.
Nikiphorou E; Norton S; Young A; Dixey J; Walsh D; Helliwell H; Kiely P;
Rheumatology (Oxford); 2018 Jul; 57(7):1194-1202. PubMed ID: 29590474
[TBL] [Abstract][Full Text] [Related]
6. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
[TBL] [Abstract][Full Text] [Related]
7. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.
Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Kerstens PJ; Nielen MM; Vos K; van Schaardenburg D; Speyer I; Seys PE; Breedveld FC; Allaart CF; Dijkmans BA
Ann Rheum Dis; 2010 Jan; 69(1):65-9. PubMed ID: 19155234
[TBL] [Abstract][Full Text] [Related]
8. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
[TBL] [Abstract][Full Text] [Related]
10. Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.
Shidara K; Nakajima A; Inoue E; Hoshi D; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
J Rheumatol; 2017 Feb; 44(2):147-153. PubMed ID: 27909083
[TBL] [Abstract][Full Text] [Related]
11. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort.
Soubrier M; Lukas C; Sibilia J; Fautrel B; Roux F; Gossec L; Patternotte S; Dougados M
Ann Rheum Dis; 2011 Apr; 70(4):611-5. PubMed ID: 21242235
[TBL] [Abstract][Full Text] [Related]
12. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
Paulshus Sundlisæter N; Olsen IC; Aga AB; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
Rheumatology (Oxford); 2018 Nov; 57(11):2022-2031. PubMed ID: 30053199
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
[TBL] [Abstract][Full Text] [Related]
14. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK
J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.
Heimans L; Wevers-de Boer KV; Koudijs KK; Visser K; Goekoop-Ruiterman YP; Harbers JB; Steup-Beekman GM; Lard LR; Grillet BA; Huizinga TW; Allaart CF
Arthritis Res Ther; 2013 Oct; 15(5):R173. PubMed ID: 24517212
[TBL] [Abstract][Full Text] [Related]
16. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
[TBL] [Abstract][Full Text] [Related]
17. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
[TBL] [Abstract][Full Text] [Related]
18. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
[TBL] [Abstract][Full Text] [Related]
19. Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort.
da Mota LM; Dos Santos Neto LL; Oliveira AC; Pereira IA; Burlingame RW; Ménard HA; Laurindo IM
Rheumatol Int; 2012 Dec; 32(12):3937-43. PubMed ID: 22198690
[TBL] [Abstract][Full Text] [Related]
20. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
